02/10/2026 | Cologne has succeeded in the highly competitive contest / Excellence funding will foster the strategic development of all the university’s areas of activity

29/09/2026 | The Clinical Infectious Diseases Section of the Department I of Internal Medicine at University Hospital Cologne has once again been recognized as a “DGI Center for Infectious Diseases” by the German Society for Infectious Diseases (DGI).

28/09/2026 | An international research team has discovered that the protein HERC4 is a key component in the signalling pathways involved in programmed cell death, which is responsible for triggering inflammatory diseases. The discovery will potentially lead the way to new therapeutic approaches for chronic inflammatory bowel diseases, rheumatism and psoriasis, as well as for inflammation-related types of cancer

24/09/2026 | Twenty professors were honoured by UNIPRENEURS for their outstanding commitment to spin-offs and entrepreneurship at universities.

16/09/2026 | The COVIM immunity platform (COllaboratiVe IMmunity Platform of the NUM), jointly established and coordinated by the Department of Virology at University Hospital Cologne and the Department of Infectious Diseases at Charité – Universitätsmedizin Berlin, will receive multimillion-euro funding from the German Federal Ministry of Research, Technology and Space as a new nationwide research infrastructure.

04/09/2026 | Professor Dr. Dr. Philipp Schommers - principle investigator at the CMMC - has been awarded a prestigious Starting Grant from the European Research Council (ERC). The ERC Starting Grant supports outstanding early-career researchers for a period of five years with funding of up to €1.5 million.